
Worked on the hartwigmedical/actin repository to deliver two core features focused on trial reporting and surgery data modeling. Enhanced trial reporting by introducing ignore and non-evaluable flags in cohort interpretation, along with new file generation for eligibility rule usage, supporting traceability and regulatory readiness. In a separate effort, refactored the surgery data model and evaluation logic to extract surgery types directly from patient records, improving rule accuracy and maintainability. Leveraged Java and Kotlin for backend development, data modeling, and JSON serialization, with a strong emphasis on code curation, refactoring, and unit testing to ensure robust, auditable business logic.
June 2025 monthly summary focusing on core business value and technical achievements for hartwigmedical/actin. Key changes center on a data-model refactor and evaluation logic upgrade for surgery data, enabling cleaner data curation and more accurate rule evaluation. The work improves maintainability, reduces manual configuration, and enhances downstream analytics by reading surgery types directly from patient records.
June 2025 monthly summary focusing on core business value and technical achievements for hartwigmedical/actin. Key changes center on a data-model refactor and evaluation logic upgrade for surgery data, enabling cleaner data curation and more accurate rule evaluation. The work improves maintainability, reduces manual configuration, and enhances downstream analytics by reading surgery types directly from patient records.
May 2025 monthly summary for hartwigmedical/actin focused on delivering Trial Reporting Enhancements to improve accuracy, auditability, and business insight into trial eligibility and rule usage. Implemented ignore/non-evaluable flags in InterpretedCohort with factory logic and enhanced trial reports; added file generation and structures to report eligibility rule usage during trial ingestion. These changes establish a traceable, data-driven foundation for trial decisions and regulatory readiness.
May 2025 monthly summary for hartwigmedical/actin focused on delivering Trial Reporting Enhancements to improve accuracy, auditability, and business insight into trial eligibility and rule usage. Implemented ignore/non-evaluable flags in InterpretedCohort with factory logic and enhanced trial reports; added file generation and structures to report eligibility rule usage during trial ingestion. These changes establish a traceable, data-driven foundation for trial decisions and regulatory readiness.

Overview of all repositories you've contributed to across your timeline